TCT 2015: Heartflow’s FFR CT Could Bring Costs Down By One-Third
This article was originally published in Clinica
HeartFlow’s FFR CT imaging system has demonstrated that it can pare off over 30% of the average cost of treating symptomatic patients at intermediate risk of coronary disease, while improving their quality of life. Experts who have reviewed the data from a cost and quality-of-life analysis of the PLATFORM trial caution, however, that this result will have to be confirmed in large randomized trials before FFR CT imaging supplants other types of noninvasive testing.
Register for our free email digests: